Tepotinib, also known as {MSC2156119|the research compound|this molecule), represents a promising step in the treatment of NSCLC, particularly in those harboring MET exon 14 mutations. This selective tyrosine kinase https://mathexyps024979.blog-gold.com/57528819/tepotinib-a-in-depth-examination-into-the-compound-and-its-possibilities